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Abstract
Introduction:  Hymenolepis nana is a zoonotic tapeworm with widespread distribution. The goal of  the present study was to 
identify the parasite in the specimens collected from NorthWestern regions of  Iran using PCR-sequencing method.
Methods: A total of  1521 stool samples were collected from the study individuals. Initially, the identification of  hymenolepis 
nana was confirmed by parasitological method including direct wet-mount and formalin-ethyl acetate concentration methods. 
Afterward, PCR-sequencing analysis of  ribosomal ITS2 fragment was targeted to investigate the molecular identification of  the 
parasite.
Results: Overall, 0.65% (10/1521) of  the isolates were contaminated with H. nana in formalin-ethyl acetate concentration. All 
ten isolates were succefully amplified by PCR and further sequenced. The determined sequences were deposited in GenBank 
under the accession numbers MH337810 -MH337819.
Conclusion: Our results clarified the presence of  H. nana among the patients in the study areas. In addition, the molecular tech-
nique could be accessible when the human eggs are the only sources available to identify and diagnose the parasite.
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Introduction
Hymenolepis nana, generally known as the dwarf  tapeworm, 
is one of  the most common tapeworms of  humans and 
rodents, in which the parasite can cause hymenolepiasis. 
This zoonotic tapeworm has a cosmopolitan distribu-
tion with socio-economic and medical significance which 
may occur in many countries, worldwide1,2. The parasite 
is among the neglected tropical diseases (NTD). Human 
hymenolepiasis caused by one of  two adult tapeworms 
Hymenolepis diminuta or Hymenolepis nana, is a globally 
widespread zoonotic infection known to be endemic in 
Asia, Southern and Eastern Europe, Central and South 
America, and Africa3,4,5. H. nana, however, accounts for 
the most common cause of  all cestode infections in hu-
mans and in temperate zones with high incidence in chil-
dren and institutionalized groups6,7. Although the extent 
of  clinical manifestations depends on the worm burden 
yet the infection with H. nana usually causes many clinical 
symptoms such as headache, weakness, anorexia, abdom-
inal pain, and diarrhea8. Infection is usually self-cleared by 
adolescence and is infrequent in healthy adults7. The drug 
of  choice to treat hymenolepiasis is praziquantel which is 
more effective than other drugs including mebendazole 
or niclosamide9.
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